[Skip to Content]
[Skip to Content Landing]
November 23/30, 2005

Conflicts of Interest and Independent Data Analysis in Industry-Funded Studies

JAMA. 2005;294(20):2575-2577. doi:10.1001/jama.294.20.2575-a

To the Editor: I am writing on behalf of the Pharmaceutical Research and Manufacturers of America (PhRMA) in response to the Editorial by Dr Fontanarosa and colleagues1 that discusses a policy that represents a change at JAMA. This change is reflected in the current JAMA Instructions for Authors2: